Rhabdoid Tumor Predisposition Syndrome 1, also known as malignant rhabdoid tumor, somatic, is related to kidney rhabdoid cancer and rhabdoid cancer. An important gene associated with Rhabdoid Tumor Predisposition Syndrome 1 is SMARCB1 (SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily B, Member 1). The drugs Cyclophosphamide and Lenograstim have been mentioned in the context of this disorder. Affiliated tissues include brain and kidney, and related phenotypes are medulloblastoma and choroid plexus carcinoma